These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [The effect of reaferon on the level of catecholamines and mitochondrial enzymes in the ischemic kidney]. Vorob'eva ND; Anikin GD; Karyshev PB Eksp Klin Farmakol; 2000; 63(2):48-50. PubMed ID: 10834094 [TBL] [Abstract][Full Text] [Related]
25. [Evaluation of 2,5-oligoadenylate synthetase and protein kinase activities in clinical studies of larifan and recombinant interferon alpha in volunteers]. Sokolova TM; Nosik NN; Lopatina OA; Krylov VF Antibiot Khimioter; 1991 Jul; 36(7):42-5. PubMed ID: 1953190 [TBL] [Abstract][Full Text] [Related]
26. Plasma and tissue pharmacokinetics of human interferon-alpha in the rat after its intravenous administration. Greig NH; Soncrant TT; Wozniak KM; Rapoport SI J Pharmacol Exp Ther; 1988 May; 245(2):574-80. PubMed ID: 2835475 [TBL] [Abstract][Full Text] [Related]
27. Scintigraphic study of radiolabelled interferon-alpha in osteosarcoma patients. Diez RA; Perdereau B; Peter M; Dorval T; Gongora R; Falcoff ET Clin Pharmacokinet; 1990 Jan; 18(1):82-9. PubMed ID: 2311332 [TBL] [Abstract][Full Text] [Related]
28. The lymphatic route. IX. Distribution of recombinant interferon-alpha 2 administered subcutaneously with oedematogenic drugs. Pessina GP; Bocci V; Carraro F; Naldini A; Paulesu L Physiol Res; 1993; 42(4):243-50. PubMed ID: 8280722 [TBL] [Abstract][Full Text] [Related]
29. [Use of reaferon and antioxidants in children with chronic hepatitis]. Frolov VM; Peresadin NA; Sidorova VS; Germanov VT; Pustovoĭ IuG Pediatriia; 1992; (4-6):60-2. PubMed ID: 1408577 [No Abstract] [Full Text] [Related]
30. [The dynamic production of interferons, interleukins and arachidonic acid metabolites by the blood cells of children with glomerulonephritis associated with HB virus infection while treated with reaferon]. Markarian AS; Malinovskaia VV; Dlin VV; Ignatov MS; Asratian AA; Pronin AV Vopr Virusol; 1993; 38(4):152-6. PubMed ID: 7694426 [TBL] [Abstract][Full Text] [Related]
31. [The production of active forms of oxygen by neutrophils in volunteers receiving leukinferon and reaferon]. Sirina EG; Tugutova IV; Zmyzgova AV; Iushchuk ND; Mesniankin AP Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):93-7. PubMed ID: 2385996 [No Abstract] [Full Text] [Related]
32. [Determination of the antiproliferative activity of human recombinant interferon (reaferon) on diploid human cells]. Svistunova EV; Denisov LA Antibiot Khimioter; 1988 Jul; 33(7):513-5. PubMed ID: 3190345 [TBL] [Abstract][Full Text] [Related]
33. [Opiate reception in the rat brain: the effect of chronic consumption of alcohol and reaferon]. Balashov AM; Petrichenko OB; Aliab'eva TN; Panchenko LF Vopr Med Khim; 1993; 39(3):43-5. PubMed ID: 8392770 [TBL] [Abstract][Full Text] [Related]
34. [Specific binding of mu- and delta-ligands by opiate receptors in the rat brain in the presence of reaferon]. Panchenko LF; Aliab'eva TN; Petrichenko OB; Bumialis VV; Balashov AM Biull Eksp Biol Med; 1988 Sep; 106(9):307-9. PubMed ID: 2844322 [TBL] [Abstract][Full Text] [Related]
35. [Use of interferon inducers and reaferon in the combined therapy of acute viral hepatitis B]. Andreĭchin MA; Rudchik AS; Borak VF Ter Arkh; 1988; 60(11):29-32. PubMed ID: 3238572 [TBL] [Abstract][Full Text] [Related]
36. [Use of recombinant alpha 2-interferon in athletes]. Ershov FI; Gotovtseva EP; Surkina ID Vopr Virusol; 1988; 33(6):693-7. PubMed ID: 3150186 [TBL] [Abstract][Full Text] [Related]
37. [Activation of phagocytosis by preparations of human alpha and gamma interferons]. Vakhrameeva NS; Avdeeva ZhE; Kuznetsov VP; Bobkova EV; Krylov OR Vopr Virusol; 1988; 33(2):181-4. PubMed ID: 3137727 [TBL] [Abstract][Full Text] [Related]
38. [Action of reaferon on a continuous human cell culture]. Amchenkova AM; Narovlianskiĭ AN; Pokidysheva LN; Voronina FV; Khesin IaE Vopr Virusol; 1988; 33(2):247-50. PubMed ID: 3414073 [No Abstract] [Full Text] [Related]
39. [Disorders of interferon status in bronchopulmonary diseases in children living under conditions of elevated background radiation]. Iakovenko LF; Spivak NIa; Ganova LA; Krivokhatskaia LD; Mazalevskiĭ AF; Radchenko NA; Ershov FI Antibiot Khimioter; 1994 Nov; 39(11):48-52. PubMed ID: 7537490 [TBL] [Abstract][Full Text] [Related]
40. [Activation of the interferon system enzymes by recombinant alpha2-interferon in patients with chronic hepatitis B]. Sokolova TM; Bugaeva NP; Suetina IA; Ershov FI; Ketiladze ES Antibiot Khimioter; 1989 Jun; 34(6):472-5. PubMed ID: 2552947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]